Galectin-1 reduced the effect of LPS on the IL-6 production in decidual cells by inhibiting LPS on the stimulation of IκBζ

Journal of Reproductive Immunology

Volumn 112, Issue , 2015, Pages 46-52

  Gómez Chávez, Fernando ^a   Castro Leyva, Violeta ^b   Espejel Núñez, Aurora ^b   Zamora Mendoza, Rubén G ^c   Rosas Vargas, Haydee ^c   Cancino Díaz, Juan C ^a   Cancino Díaz, Mario E ^a   Estrada Gutierrez, Guadalupe ^b   Rodríguez Martínez, Sandra ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Galectin 1; IL 6; I B ; NF B; Pregnancy

Indexed keywords

GALECTIN 1; I KAPPA B BETA XI; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; I KAPPA B; IL6 PROTEIN, HUMAN; LGALS1 PROTEIN, HUMAN; NFKBIE PROTEIN, HUMAN; ONCOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DECIDUA; DECIDUA CELL; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; PLACENTA; PREGNANCY;

ADULT; CELLS, CULTURED; DECIDUA; FEMALE; GALECTIN 1; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PLACENTA; PREGNANCY; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84947777360     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2015.07.002     Document Type: Article

References (43)

1. Abrahams V.M., Kim Y.M., Straszewski S.L., Romero R., Mor G. Macrophages and apoptotic cell clearance during pregnancy. Am. J. Reprod. Immunol. 2004, 51:275-282. 10.1111/j.1600-0897.2004.00156.x.
2. Arntzen K.J., Kjøllesdal A.M., Halgunset J., Vatten L., Austgulen R. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J. Perinat. Med. 1998, 26:17-26.
3. Blidner A.G., Rabinovich G.A. Sweeteningpregnancy: galectins at the fetomaternal interface. Am. J. Reprod. Immunol. 2013, 10.1111/aji.12090.
4. Blois S.M., Barrientos G. Galectin signature in normal pregnancy and preeclampsia. J. Reprod. Immunol. 2014, 101:127-134. 10.1016/j.jri.2013.05.005.
5. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13(12):1450-1457. 10.1038/nm1680.
6. Castro-Leyva V., Espejel-Nuñez A., Barroso G., Zaga-Clavellina V., Flores-Pliego A., Morales-Mendez I., Giono-Cerezo S., Walsh W.S., Estrada-Gutierrez G. Preserved ex vivo inflammatory status in decidual cells from women with preterm labor and subclinical intrauterine infection. PLoS One 2012, 7:e43605. 10.1371/journal.pone.0043605.
7. Cedeno-Laurent F., Opperman M., Barthel S.R., Kuchroo V.K., Dimitroff C.J. Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 2012, 188:3127-3137. 10.4049/jimmunol.1103433.
8. Clark D.A. Popular myths in reproductive immunology. J. Reprod. Immunol. 2014, 104-105:54-62. 10.1016/j.jri.2014.06.002.
9. Cookson V.J., Chapman N.R. NF-kappaB function in the human myometrium during pregnancy and parturition. Histol. Histopathol. 2010, 25:945-956.
10. Cowland J.B., Muta T., Borregaard N. IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J. Immunol. 2006, 176:5559-5566.
11. Di Lella S., Sundblad V., Cerliani J.P., Guardia C.M., Estrin D.A., Vasta G.R., Rabinovich G.A. When galectins recognize glycans: from biochemistry to physiology and back again. Biochemistry 2011, 50:7842-7857. 10.1021/bi201121m.
12. Dudley D.J., Trautman M.S., Araneo B.A., Edwin S.S., Mitchell M.D. Decidual cell biosynthesis of interleukin-6: regulation by inflammatory cytokines. J. Clin. Endocrinol. Metab. 1992, 74:884-889. 10.1210/jcem.74.4.1548355.
13. Friebe A., et al. Neutralization of lps or blockage of tlr4 signaling prevents stress-triggered fetal loss in murine pregnancy. J. Mol. Med. 2011, 89:689-699.
14. Ghosh S., Hayden M.S. New regulators of NF-|[kappa]|B in inflammation. Nat. Rev. Immunol. 2008, 8:837-848. 10.1038/nri2423.
15. Hildebrand D.G., Alexander E., Hörber S., Lehle S., Obermayer K., Münck N.-A., Rothfuss O., Frick J.-S., Morimatsu M., Schmitz I., Roth J., Ehrchen J.M., Essmann F., Schulze-Osthoff K. IκBζ Is a transcriptional key regulator of CCL2/MCP-1. J. Immunol. 2013, 10.4049/jimmunol.1300089.
16. Hunt J.S., Petroff M.G., McIntire R.H., Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005, 19:681-693. 10.1096/fj.04-2078rev.
17. Ilarregui J.M., Rabinovich G.A. Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: an emerging role of protein-glycan interactions. Neuroimmunomodulation 2010, 17:157-160. 10.1159/000258712.
18. Jacobsson B.O., Holst R.M., Wennerholm U.B. Monocyte chemotactic protein-1 in cervical and amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra-amniotic inflammation, and preterm delivery. Am. J. Obstet. Gynecol. 2003, 189:1161-1167. 10.1067/S0002-9378(03)594-5.
19. Kasai K., Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J. Biochem. 1996, 119:1-8.
20. Kayama H., Ramirez-Carrozzi V.R., Yamamoto M., Mizutani T., Kuwata H., Iba H., Matsumoto M., Honda K., Smale S.T., Takeda K. Class-specific regulation of pro-inflammatory genes by MyD88 pathways and IkappaBzeta. J. Biol. Chem. 2008, 283:12468-12477. 10.1074/jbc.M709965200.
21. Kopcow H.D., Rosetti F., Leung Y., Allan D.S.J., Kutok J.L., Strominger J.L. T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18472-18477. 10.1073/pnas.0809233105.
22. Lappas M., Rice G.E. The role and regulation of the nuclear factor kappa B signalling pathway in human labour. Placenta 2007, 28:543-556. 10.1016/j.placenta.2006.05.011.
23. Motran C.C., Molinder K.M., Liu S.D., Poirier F., Miceli M.C. Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur. J. Immunol. 2008, 38:3015-3027. 10.1002/eji.200838295.
24. Muta T. IκB-ζ: an inducible regulator of nuclear factor-κB. Interleukins, Vitamins & Hormones 2006, 301-316. Elsevier. 10.1016/S0083-6729(06)74012-2.
25. Okamoto K., Iwai Y., Oh-hora M., Yamamoto M., Morio T., Aoki K., Ohya K., Jetten A.M., Akira S., Muta T., Takayanagi H. IkappaBzeta regulates T(H) 17 development by cooperating with ROR nuclear receptors. Nature 2010, 464:1381-1385. 10.1038/nature08922.
26. Poirier F., Robertson E.J. Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 1993, 119:1229-1236.
27. Rabinovich G.A., Toscano M.A. Turning sweet on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352. 10.1038/nri2536.
28. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 1999, 190:385-398.
29. Raices R.M., Kannan Y., Bellamkonda-Athmaram V., Seshadri S., Wang H., Guttridge D.C., Wewers M.D. A novel role for IκBζ in the regulation of IFNγ production. PLoS One 2009, 4:e6776. 10.1371/journal.pone.0006776.
30. Ramhorst R.E., Giribaldi L., Fraccaroli L., Toscano M.A., Stupirski J.C., Romero M.D., Durand E.S., Rubinstein N., Blaschitz A., Sedlmayr P., Genti-Raimondi S., Fainboim L., Rabinovich G.A. Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss. Glycobiology 2012, 22:1374-1386. 10.1093/glycob/cws104.
31. Rodríguez Martínez S., Cancino Diaz M.E., Miguel P.-S., Cancino Diaz J.C. Lipopolysaccharide from E. coli induces the expression of vascular endothelial growth factor via toll-like receptor 4 in human limbal fibroblasts. Exp. Eye Res. 2006, 83:1373-1377. 10.1016/j.exer.2006.07.015.
32. Roncari D., Politch J.A., Sonalkar S., Finneseth M., Borgatta L. Inflammation or infection at the time of second trimester induced abortion. Contraception 2013, 87:67-70. 10.1016/j.contraception.2012.09.016.
33. Rubinstein N., Alvarez M., Zwirner N.W., Toscano M.A., Ilarregui J.M., Bravo A., Mordoh J., Fainboim L., Podhajcer O.L., Rabinovich G.A. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege. Cancer Cell 2004, 5:241-251. 10.1038/nrc1345.
34. Saito S., Nakashima A., Shima T., et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010, 63:601-610. 10.1111/j.1600-0897.2010.00852.x.
35. Starossom S.C., Mascanfroni I.D., Imitola J., Cao L., Raddassi K., Hernandez S.F., Bassil R., Croci D.O., Cerliani J.P., Delacour D., Wang Y., Elyaman W., Khoury S.J., Rabinovich G.A. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012, 37:249-263. 10.1016/j.immuni.2012.05.023.
36. Than N.G., Romero R., Erez O., Weckle A., Tarca A.L., Hotra J., Abbas A., Han Y.M., Kim S.-S., Kusanovic J.P., Gotsch F., Hou Z., Santolaya-Forgas J., Benirschke K., Papp Z., Grossman L.I., Goodman M., Wildman D.E. Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15819-15824. 10.1073/pnas.0807606105.
37. Thaxton J.E., et al. Tlr9 activation coupled to il-10 deficiency induces adverse pregnancy outcomes. J. Immunol. 2009, 183:1144-1154. 10.4049/jimmunol.0900788.
38. Toscano M.A., Commodaro A.G., Ilarregui J.M., Bianco G.A., Liberman A., Serra H.M., Hirabayashi J., Rizzo L.V., Rabinovich G.A. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006, 176:6323-6332. 10.4049/jimmunol.176.10.6323.
39. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., Zwirner N.W., Poirier F., Riley E.M., Baum L.G., Rabinovich G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007, 8:825-834. 10.1038/ni1482.
40. Woidacki K., Popovic M., Metz M., Schumacher A., Linzke N., Teles A., Poirier F., Fest S., Jensen F., Rabinovich G.A., Maurer M., Zenclussen A.C. Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death Dis. 2013, 4:e462. 10.1038/cddis.2012.214.
41. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., Kaisho T., Kuwata H., Takeuchi O., Takeshige K., Saitoh T., Yamaoka S., Yamamoto N., Yamamoto S., Muta T., Takeda K., Akira S. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein I[kappa]B[zeta]. Nature 2004, 430:218-222. 10.1038/nature02738.
42. Yamazaki S., Muta T., Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 2001, 276:27657-27662. 10.1074/jbc.M103426200.
43. Yamazaki S., Muta T., Matsuo S., Takeshige K. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J. Biol. Chem. 2005, 280:1678-1687. 10.1074/jbc.M409983200.